StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Evogene Price Performance Shares of EVGN stock opened at $0.77 on Friday. The company has a market capitalization of $31.73 million, a PE ratio of -1.67 […]